0001825079
EX-FILING FEES
0001825079
2026-01-13
2026-01-13
0001825079
1
2026-01-13
2026-01-13
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
Exhibit
107
Calculation
of Filing Fee Tables
Form
S-3
(Form
Type)
Velo3D,
Inc.
(Exact
Name of Registrant as Specified in its Charter)
Table
1: Newly Registered Securities
| | |
Security Type | |
Security Class Title | | |
Fee Calculation Rule | | |
Amount Registered | | |
Proposed Maximum Offering Price Per Unit | | |
Maximum Aggregate Offering Price | | |
Fee Rate | | |
Amount of Registration Fee | |
| Fees to Be Paid | |
Equity(1) | |
| Common stock, par value $0.00001 per share | | |
| 457 | (c) | |
| 3,636,363 | | |
$ | 18.55 | | |
$ | 67,454,533.65 | | |
| 0.00013810 | | |
$ | 9,315.47 | |
| Fees Previously Paid | |
- | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| | |
Total Offering Amounts | | |
| | | |
$ | 67,454,533.65 | | |
| | | |
$ | 9,315.47 | |
| | |
Total Fees Previously Paid | | |
| | | |
| | | |
| | | |
$ | 0 | |
| | |
Total Fee Offsets | | |
| | | |
| | | |
| | | |
$ | 0 | |
| | |
Net Fee Due | | |
| | | |
| | | |
| | | |
$ | 9,315.47 | |
| (1) | Pursuant
to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”),
this registration statement also covers an indeterminate number of additional shares as may
be issuable as a result of stock splits, stock dividends or similar transactions. All 3,636,363
shares of common stock of the registrant are to be offered for resale by the selling stockholders
named in the prospectus contained in this Registration Statement on Form S-3 (the “Registration
Statement”). |
Pursuant
to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering
price per share is the average of the high and low prices reported for the registrant’s common stock quoted on the Nasdaq Capital
Market on January 7, 2026, which is a date within five
(5) business days prior to the filing date of the Registration Statement.
N/A